96 related articles for article (PubMed ID: 24423330)
1. Growth patterns of pituitary adenomas and histopathological correlates.
Monsalves E; Larjani S; Loyola Godoy B; Juraschka K; Carvalho F; Kucharczyk W; Kulkarni A; Mete O; Gentili F; Ezzat S; Zadeh G
J Clin Endocrinol Metab; 2014 Apr; 99(4):1330-8. PubMed ID: 24423330
[TBL] [Abstract][Full Text] [Related]
2. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.
Tanaka Y; Hongo K; Tada T; Sakai K; Kakizawa Y; Kobayashi S
J Neurosurg; 2003 Feb; 98(2):359-65. PubMed ID: 12593623
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas.
Sarkar S; Chacko AG; Chacko G
J Clin Neurosci; 2015 Jul; 22(7):1173-7. PubMed ID: 25979255
[TBL] [Abstract][Full Text] [Related]
5. Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics.
Balogun JA; Monsalves E; Juraschka K; Parvez K; Kucharczyk W; Mete O; Gentili F; Zadeh G
Endocr Pathol; 2015 Mar; 26(1):63-70. PubMed ID: 25403448
[TBL] [Abstract][Full Text] [Related]
6. Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study.
Honegger J; Ernemann U; Psaras T; Will B
Acta Neurochir (Wien); 2007 Jan; 149(1):21-9; discussion 29. PubMed ID: 17086476
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Pathologic Characteristics Predicted the Postoperative Recurrence and Progression of Pituitary Adenoma: A Retrospective Study with 10 Years Follow-Up.
Lv L; Yin S; Zhou P; Hu Y; Chen C; Ma W; Jiang Y; Wang Z; Jiang S
World Neurosurg; 2018 Oct; 118():e428-e435. PubMed ID: 29981466
[TBL] [Abstract][Full Text] [Related]
8. [Natural history study of postoperative residual non-functioning pituitary adenomas].
Wu ZB; Chen Y; Lü QP; Wang CD; Su ZP; Wu JS; Zheng WM; Zhuge QC
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):597-600. PubMed ID: 20450781
[TBL] [Abstract][Full Text] [Related]
9. Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.
Øystese KA; Zucknick M; Casar-Borota O; Ringstad G; Bollerslev J
Endocrine; 2017 Jul; 57(1):35-45. PubMed ID: 28516382
[TBL] [Abstract][Full Text] [Related]
10. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E
Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings.
Vieira JO; Cukiert A; Liberman B
Surg Neurol; 2006 Feb; 65(2):130-5; discussion 135. PubMed ID: 16427401
[TBL] [Abstract][Full Text] [Related]
12. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
[TBL] [Abstract][Full Text] [Related]
14. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy.
Lee S; Kim SJ; Yu YS; Kim YH; Paek SH; Kim DG; Jung HW
Br J Neurosurg; 2013 Aug; 27(4):425-9. PubMed ID: 23421587
[TBL] [Abstract][Full Text] [Related]
16. Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results.
Losa M; Franzin A; Mangili F; Terreni MR; Barzaghi R; Veglia F; Mortini P; Giovanelli M
Neurosurgery; 2000 Dec; 47(6):1313-8; discussion 1318-9. PubMed ID: 11126902
[TBL] [Abstract][Full Text] [Related]
17. Gender-related differences in non-functioning pituitary adenomas.
Schaller B
Neuro Endocrinol Lett; 2003 Dec; 24(6):425-30. PubMed ID: 15073569
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma.
Hsu CY; Guo WY; Chien CP; Ho DM
Eur J Endocrinol; 2010 Jun; 162(6):1027-33. PubMed ID: 20231369
[TBL] [Abstract][Full Text] [Related]
19. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst.
Shin JL; Asa SL; Woodhouse LJ; Smyth HS; Ezzat S
J Clin Endocrinol Metab; 1999 Nov; 84(11):3972-82. PubMed ID: 10566636
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma.
Gopalan R; Schlesinger D; Vance ML; Laws E; Sheehan J
Neurosurgery; 2011 Aug; 69(2):284-93. PubMed ID: 21792138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]